716 results on '"Segev D."'
Search Results
2. Higher Donor Sequence Numbers are Not Associated with Worse Lung Transplant Outcomes
3. Survival in Alpha-1 Antitrypsin (A1AT) Deficient Lung Transplant Recipients by Use of A1AT Augmentation Therapy
4. Early Hospital Readmission After Simultaneous Pancreas-Kidney Transplantation: Patient and Center-Level Factors.
5. Urinary concentrations of organophosphate and carbamate pesticides in residents of a vegetarian community
6. Physical activity – does it really increase bone density in post-menopausal women? – Review of articles published between 2001-2015 / פעילות גופנית – האם היא באמת ״בונה עצם״ בקרב נשים לאחר גיל המעבר? סקירת מאמרים שפורסמו בשנים 2015-2001
7. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative endpoints for next‐generation clinical trials
8. Antibody‐mediated rejection: New approaches in prevention and management
9. Pre‐Kidney Transplant Lower Extremity Impairment and Post‐Kidney Transplant Mortality
10. Technical Note - An Approximate Dynamic Programming Approach to The Incremental Knapsack Problem
11. The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis
12. Impact of Protease Inhibitor–Based Anti‐Retroviral Therapy on Outcomes for HIV+ Kidney Transplant Recipients
13. The National Landscape of Living Kidney Donor Follow‐Up in the United States
14. The Living Donor Collective: A Scientific Registry for Living Donors
15. PROviding Better ACcess To ORgans: A comprehensive overview of organ‐access initiatives from the ASTS PROACTOR Task Force
16. Considering Tangible Benefit for Interdependent Donors: Extending a Risk–Benefit Framework in Donor Selection
17. Predonation Prescription Opioid Use: A Novel Risk Factor for Readmission After Living Kidney Donation
18. Waitlist Outcomes of Liver Transplant Candidates Who Were Reprioritized Under Share 35
19. Changes in Utilization and Discard of Hepatitis C–Infected Donor Livers in the Recent Era
20. The Changing Financial Landscape of Renal Transplant Practice: A National Cohort Analysis
21. POS0256 CLINICAL PREDICTORS OF ATTENUATED ANTIBODY RESPONSE TO PRIMARY SARS-CoV-2 VACCINATION IN A LARGE PROSPECTIVE STUDY OF PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES
22. Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)–Infected Recipients
23. Enlightenment versus Religious Law
24. Perioperative Complications After Living Kidney Donation: A National Study
25. Economic Impacts of ABO-Incompatible Live Donor Kidney Transplantation: A National Study of Medicare-Insured Recipients
26. (922) - Factors Associated with Long Survival Following Single Lung Transplantation
27. (351) - Higher Donor Sequence Numbers are Not Associated with Worse Lung Transplant Outcomes
28. (54) - Survival in Alpha-1 Antitrypsin (A1AT) Deficient Lung Transplant Recipients by Use of A1AT Augmentation Therapy
29. Where the Sun Shines: Industryʼs Payments to Transplant Surgeons
30. Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation
31. Landscape of Deceased Donors Labeled Increased Risk for Disease Transmission Under New Guidelines
32. The Best-Laid Schemes of Mice and Men Often Go Awry; How Should We Repair Them?
33. Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected Recipients
34. Challenges and Clinical Decision-Making in HIV-to-HIV Transplantation: Insights From the HIV Literature
35. Consensus Conference on Best Practices in Live Kidney Donation: Recommendations to Optimize Education, Access, and Care
36. Early Changes in Liver Distribution Following Implementation of Share 35
37. Quantifying Renal Allograft Loss Following Early Antibody-Mediated Rejection
38. Loss of Pediatric Kidney Grafts During the “High–Risk Age Window”: Insights From Pediatric Liver and Simultaneous Liver–Kidney Recipients
39. Frailty and Mortality in Kidney Transplant Recipients
40. Variation in Biliary Complication Rates Following Liver Transplantation: Implications for Cost and Outcome
41. Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients
42. Survival Benefit of Primary Deceased Donor Transplantation With High-KDPI Kidneys
43. Experiences Obtaining Insurance After Live Kidney Donation
44. Association Between Liver Transplant Center Performance Evaluations and Transplant Volume
45. Big Data in Organ Transplantation: Registries and Administrative Claims
46. Quantifying the Risk of Incompatible Kidney Transplantation: A Multicenter Study
47. Blood Dendritic Cell Levels Associated With Impaired IL-12 Production and T Cell Function in Kidney Disease: Implications for Post-Transplant Viral Infections.: Abstract# A35
48. Current State of Living Kidney Donor Follow-Up in the United States and the New OPTN Reporting Requirements.: Abstract# D2746
49. The Evolution of the Facebook Living Donor App.: Abstract# C2084
50. Transplant Center Performance Evaluations Are Highly Sensitive to Changes in Model Discrimination.: Abstract# B1220
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.